genXone

13 August 2020

Resolution No. 604/2020 of the Warsaw Stock Exchange Management Board

Resolution No. 604/2020of the Warsaw Stock Exchange Management Board dated 12 August 2020concerning introduction of series A, B, C and D bearer ordinary shares of the company GENXONE S.A. to the alternative trading system on the NewConnect market § 1 Pursuant to § 5.1 in connection with § 3.1 and § 3.2 of the Alternative Trading System […]

27 July 2020

next.gazeta.pl article

This time it is about molecular research and the way to the stock exchange. https://next.gazeta.pl/next/7,161716,26150903,chca-przekonac-polakow-do-molekularnych-badan-diagnostycznych.html

17 July 2020

Innpoland article about R&D lab

Click to read aninteresting article with beautiful pictures from our R&D lab https://innpoland.pl/160757,genxone-spod-poznania-bada-koronawirusa-i-tworzy-jego-mape-genetyczna

1 July 2020

Increasing the Molecular Diagnostic Lab throughput

In June 202, the Company purchased laboratory equipment – a semi-automatic diagnostic system consisting of two devices: NIMBUS IVD pipetting station and CFX DX Real Time PCR System which will increase the throughput of up to 1000 samples per day. The total purchase cost is 415,800,00 gross.

22 June 2020

Polish Capital Market Days online edition 2020

On June 22, 2020, CEO Michał Kaszuba presented the current Company’s plans and activities during the Polish Capital Market Days – ONLINE EDITION 2020 teleconference. The report from this event can be viewed here:

10 June 2020

genXone joins the international project

While the Molecular Diagnostics Laboratory has exceeded the number of 1500 performed tests for COVID-19, employees of the R&D Laboratory and bioinformatics joined the international research project. Its aim is to identify the risk group and early diagnosis of early-age colorectal cancer

25 May 2020

10 000 COVID-19 tests!

The genXone Molecular Diagnostics Laboratory has performed over 10,000 tests for COVID-19! This is a great accomplishment made possible by the team’s great effort and modern equipment. The laboratory pavilion works perfectly and confirms the purposefulness of the investment.

14 May 2020

genXone listed as an interesting debut

At the beginning of the week, an article on the nearest NewConnect debuts appeared on the websites of spalainwestorow.pl. GenXone SA is described as one of the most interesting upcoming debuts. Link to the article (polish): https://strefainwestorow.pl/artykuly/debiut-ipo/20200512/debiuty-ipo-2020#st1

6 May 2020

Launch of the Mobile Laboratory Pavillon

At the beginning of the new month, laboratory work related to COVID-19 diagnostics was moved to a new location. The container laboratory is a fully equipped unit that will significantly increase the work capacity. The team of laboratory diagnosticians has also been strengthened.